Davita-Mountain Vista Dialysis Center is a medicare approved dialysis facility center in San Bernardino, California and it has 28 dialysis stations. It is located in San Bernardino county at 4041 University Parkway, San Bernardino, CA, 92407. You can reach out to the office of Davita-Mountain Vista Dialysis Center at (909) 887-0173. This dialysis clinic is managed and/or owned by Davita. Davita-Mountain Vista Dialysis Center has the following ownership type - Profit. It was first certified by medicare in January, 1994. The medicare id for this facility is 052743 and it accepts patients under medicare ESRD program.
Name | Davita-Mountain Vista Dialysis Center |
---|---|
Location | 4041 University Parkway, San Bernardino, California |
No. of Dialysis Stations | 28 |
Medicare ID | 052743 |
Managed By | Davita |
Ownership Type | Profit |
Late Shifts | No |
4041 University Parkway, San Bernardino, California, 92407 | |
(909) 887-0173 | |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
NPI Number | 1902869357 |
Organization Name | Mountain Vista Dialysis Center |
Doing Business As | Renal Treatment Centers California Inc |
Address | 4041 University Pkwy San Bernardino, California, 92407 |
Phone Number | (909) 887-0173 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that nephrologists always communicated and cared for them. | 67% | 67% |
Patients who reported that nephrologists usually communicated and cared for them. | 16% | 15% |
Patients who reported that nephrologists sometimes or never communicated and cared for them. | 17% | 18% |
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 57% | 60% |
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 20% | 14% |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 63% | 62% |
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 19% | 20% |
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 18% | 18% |
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 61% | 62% |
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 26% |
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 12% |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Experience Measure | Provider | National Avg. |
---|---|---|
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 75% | 80% |
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 25% | 20% |
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 69% | 68% |
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 20% |
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 18% | 12% |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Dialysis patients with Hemoglobin data | 62 |
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 19 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 185 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 1744 |
Percentage of adult patients getting regular hemodialysis at the center | 95 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Adult patients getting regular peritoneal dialysis at the center | 28 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 249 |
Percentage of adult patients getting regular peritoneal dialysis at the center | 88 |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Mountain Vista Dialysis Center with elevated calcium levels.
Patients with hypercalcemia | 220 |
Hypercalcemia patient months | 2088 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
Patients with Serumphosphor | 227 |
Patients with Serumphosphor less than 3.5 mg/dL | 12 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 31 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 18 |
Patients with Serumphosphor greater than 7 mg/dL | 16 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 83 |
Patient months included in arterial venous fistula and catheter summaries | 667 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 54 |
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 143 |
Hospitalization Rate in facility | 219.2 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 340.3 |
Hospitalization Rate: Lower Confidence Limit | 151 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita-Mountain Vista Dialysis Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 19.5 (As Expected) |
Readmission Rate: Upper Confidence Limit | 27 |
Readmission Rate: Lower Confidence Limit | 13.4 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita-Mountain Vista Dialysis Center get infections in their blood each year compared to the number of infections expected for the center based on the national average.
Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
Infection Rate in facility | 1.21 (As Expected) |
SIR: Upper Confidence Limit | 1.9 |
SIR: Lower Confidence Limit | .73 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita-Mountain Vista Dialysis Center's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
Patients in facility's Transfusion Summary | 135 |
Transfusion Rate in facility | 51.6 (As Expected) |
Transfusion Rate: Upper Confidence Limit | 93.7 |
Transfusion Rate: Lower Confidence Limit | 30.5 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita-Mountain Vista Dialysis Center lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
Patients in facility's Survival Summary | 949 |
Mortality Rate in facility | 16.5 (As Expected) |
Mortality Rate: Upper Confidence Limit | 20.4 |
Mortality Rate: Lower Confidence Limit | 13.2 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago
Fmc-Rai-North Waterman-San Bernardino Location: 1500 N. Waterman Avenue, San Bernardino, California, 92404 Phone: (909) 381-1591 |
Davita-Mountain Vista Dialysis Center Location: 4041 University Parkway, San Bernardino, California, 92407 Phone: (909) 887-0173 |
Fmc-San Bernardino Location: 636 E. Brier Drive, Suite 150, San Bernardino, California, 92408 Phone: (909) 890-9508 |
Davita-Citrus Valley Dialysis Location: 894 Hardt Street, San Bernardino, California, 92408 Phone: (909) 388-6608 |
SAN Bernardino Valley Home Dialysis Center Location: 1500 N. Waterman Avenue, Suite B, San Bernardino, California, 92404 Phone: (909) 381-1595 |
News Archive
Many medical tests that once required sending samples to a laboratory and waiting for results can now be rapidly performed at the patient's bedside. As these point-of-care testing (POCT) technologies are increasingly integrated into patient care, careful attention is needed to protect patient safety and avoid medical errors, according to this month's special issue of Point of Care: The Journal of Near-Patient Testing & Technology.
A meta-analysis of non-human primate (NHP) studies showed that adeno-associated virus (AAV) gene therapy often caused dorsal root ganglion (DRG) pathology.
The heart of Bellevue now boasts a new senior living community that is perfectly suited to the needs and desires for residents of the Eastside. Aegis Living, a national leader in senior, assisted living and memory care communities, recently opened its 34th community to a crowd of hundreds, as new and prospective residents and families came to celebrate the grand opening event.
Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company's increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.
› Verified 6 days ago